HORIZON (OP-106): Melflufen Plus Dexamethasone in 55 Patients with Relapsed/Refractory Multiple Myeloma (RRMM) with Extramedullary Disease (EMD): Subgroup Analysis - Richardson, Paul G; Richardson, Paul G; Mateos, Maria-Victoria; Oriol, Albert; Larocca, Alessandra; Cavo, Michele; Rodriguez-Otero, Paula; Leleu, Xavier; Norkin, Maxim; Nadeem, Omar; Hiemenz, John W; Hiemenz, John W; et al. (Clinical Lymphoma Myeloma & Leukemia, 2021)